Closing the Diversity Gap in Clinical Trials

Clinical trials are at the heart of the process for bringing new medicines to patients. While modern researchers can do more with molecules in the laboratory than ever before, and preclinical analysis of a compound can provide important evidence about its potential value in treating disease, it’s impossible to determine the safety and effectiveness of a new medicine until it’s tested in human beings.

Read more at Forbes.com